上海锦天城（广州）律师事务所 关于重庆登康口腔护理用品股份有限公司 2026 年第一次临时股东会的 法律意见书 地址：广州市天河区珠江西路 5 号广州国际金融中心第 60 层 电话：020-8928 1168 传真：020-8928 5188 邮编：510623 上海锦天城（广州）律师事务所 法律意见书 上海锦天城（广州）律师事务所 关于重庆登康口腔护理用品股份有限公司 2026 年第一次临时股东会的 法律意见书 致：重庆登康口腔护理用品股份有限公司 上海锦天城（广州）律师事务所（以下简称"本所"）接受重庆登康口腔护 理用品股份有限公司（以下简称"公司"）委托，就公司召开 2026 年第一次临时 股东会（以下简称"本次股东会"或"本次会议"）的有关事宜，根据《中华人民 共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》（以下简 称"《证券法》"）和《上市公司股东会规则》（以下简称"《股东会规则》"）、 《深圳证券交易所上市公司股东会网络投票实施细则》等法律、法规、规章和 其他规范性文件以及《重庆登康口腔护理用品股份有限公司章程》（以下简称 "《公司章程》"）的有关规定，出具本法律意见书。 对本 ...

证券代码：001328 证券简称：登康口腔 公告编号：2026-007 重庆登康口腔护理用品股份有限公司 2026年第一次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 特别提示： 1. 本次股东会无否决议案或修改议案的情况； 2. 本次股东会上没有新提议案提交表决； 3. 本次股东会不涉及变更前次股东会决议的情况； 4. 本次股东会采取现场方式召开，采用现场投票和网络投票相结合的方式进行表 决。 一、会议召开情况 （一）会议召开时间 重庆登康口腔护理用品股份有限公司（以下简称"公司"）董事会。 （四）现场会议召开地点 公司办公楼一楼报告厅（重庆市两江新区海尔路389号）。 - 1 - 1. 现场会议召开时间：2026年2月10日（星期二）14:30。 2. 网络投票时间： （1）深圳证券交易所交易系统进行网络投票的具体时间为2026年2月10日 9:15— 9:25，9:30—11:30和13:00—15:00； （2）深圳证券交易所互联网投票系统投票的具体时间为2026年2月10日 9:15- 15:00。 （二）会议召开和表决方式 本 ...

Group 1 - The State Council will hold a press conference regarding the "Accelerating the Cultivation of New Growth Points in Service Consumption Work Plan" on February 6 at 3 PM [1] Group 2 - On February 6, a total of 7 companies will have their restricted shares unlocked, with a total unlock volume of 33.61 million shares, amounting to a market value of 5.243 billion yuan [2] - The companies with the highest unlock volumes are Xinghuan Technology-U, Dengkang Dental, and Hansan Technology, with unlock shares of 27.16 million, 2.99 million, and 1.52 million respectively [2] - In terms of unlock market value, Xinghuan Technology-U, Dengkang Dental, and Hansan Technology lead with values of 4.985 billion yuan, 130 million yuan, and 8.616 million yuan respectively [2] Group 3 - Eight companies disclosed stock repurchase progress on February 6, with 2 companies announcing new repurchase plans, 2 companies having their plans approved by shareholders, and 4 companies completing their repurchase plans [3] - The newly announced repurchase plans include Haizheng Pharmaceutical and Huatong Cable, with intended repurchase amounts of up to 726,400 yuan and 296,800 yuan respectively [3] - The companies that received shareholder approval for their repurchase plans are Hengtong Co. and Hongtai Sun, with intended repurchase amounts of up to 100 million yuan and 215,000 yuan respectively [3]

Market Overview - The Chongqing state-owned enterprise reform sector declined by 0.7% compared to the previous trading day, with Chongqing Pharmaceutical Holdings leading the decline [1] - The Shanghai Composite Index closed at 4128.37, up 0.13%, while the Shenzhen Component Index closed at 14210.63, up 0.02% [1] Stock Performance - Notable stock performances include: - Shanghai Sanmao (600689) closed at 14.29, up 0.78% with a trading volume of 30,300 shares and a turnover of 43.27 million yuan - Chongqing Construction (600939) closed at 3.23, up 0.31% with a trading volume of 133,800 shares and a turnover of 43.05 million yuan - Chongqing Pharmaceutical Holdings (000950) closed at 5.90, down 1.83% with a trading volume of 366,700 shares and a turnover of 218 million yuan [1][2] Capital Flow - The Chongqing state-owned enterprise reform sector experienced a net outflow of 119 million yuan from institutional investors, while retail investors saw a net inflow of 62.65 million yuan [2] - The capital flow for individual stocks shows: - Jieling Pickled Vegetables (002507) had a net inflow of 5.71 million yuan from institutional investors, but a net outflow of 13.01 million yuan from retail investors [3] - Chongqing Water (601158) had a net outflow of 3.40 million yuan from institutional investors, with a net inflow of 1.18 million yuan from retail investors [3]

Summary of the Conference Call for Dengkang Oral Care Company Overview - **Company**: Dengkang Oral Care - **Industry**: Oral Care Products Key Points Strategic Direction - The strategic tone for 2026 is "steady progress" with a focus on optimizing profitability through adjustments in e-commerce platform allocations [2][6][10] - Plans to reduce reliance on Douyin (TikTok) from over 40% to below 40%, maintain Tmall at around 30%, and increase JD's share to over 20% [2][5][7][10] E-commerce Performance - As of early 2026, overall profit margins across e-commerce platforms are stable at approximately 5-6%, with JD performing the best, followed by Tmall, and Douyin slightly below average [2][5][7] - The company aims to enhance profitability by reallocating resources to higher-margin platforms [5][16] Product Strategy - Dengkang is focusing on product premiumization, targeting an increase in ultra-high-end products (priced above 30 RMB) from 20% to around 30% of total sales [2][11][12] - The new keratin toothpaste launched in August 2025 has monthly sales exceeding 10 million RMB, with a target of 20-30 million RMB per month in 2026 [2][13] Market Trends and Challenges - The overall industry remains challenging, with many emerging brands operating at a loss, particularly on platforms like Douyin [9][21] - Despite a general decline in the oral care market, Dengkang has achieved nearly double-digit growth, contrasting with an industry decline of about 8% [21][22] Future Plans - 2026 is designated as the year for overseas market expansion, particularly in Southeast Asia, with a sales target of several million RMB [5][18] - The company plans to implement a three-step strategy for international expansion: brand establishment, building offline channels, and supply chain development [5][18] Manufacturing and Supply Chain - Dengkang employs a light asset operation model, outsourcing lower-end product manufacturing while maintaining high-end production in-house [19] - The inventory cycle is currently 30-40 days, significantly shorter than the industry average of 90-120 days, indicating efficient inventory management [16] Investment and Growth Areas - Future investments will focus on the oral health ecosystem, including smart oral care and digital transformation [24][25] - The company is also exploring mergers and acquisitions to enhance growth potential in the oral care sector [24] Shareholder Actions - Shareholder reduction plans are based on individual decisions, with expectations for future stock price growth influencing timing [26] This summary encapsulates the key insights and strategic directions discussed during the conference call, highlighting Dengkang Oral Care's focus on profitability, product premiumization, and market expansion.

Investment Rating - The report assigns an "Accumulate" rating for the cosmetics industry, indicating a positive outlook for selected companies within the sector [5]. Core Insights - The beauty industry is expected to maintain steady growth in 2026, driven by product innovation and the rising trend of domestic brands. The report suggests a bottom-up selection of high-growth products and brands with strong potential, as well as companies that exhibit resilience amid product and channel changes [2][5]. Summary by Sections Industry Overview - The report highlights that the cosmetics sales during the off-peak season have shown marginal improvement. It suggests focusing on products and brands with strong growth momentum and resilience in the face of changing product and channel dynamics [2]. Key Investment Points - The report identifies two main lines of investment: 1. **High-Growth Companies**: Companies like RuYuchen, BeiJiaJie, MaoGePing, LinQingXuan, and ShangMei are expected to perform well due to strong fundamentals and product innovation [5]. 2. **Brands with Strong Asset Value**: Companies such as BeiTaiNi and PoLaiYa are anticipated to see marginal improvements following adjustments in their channels and product structures [5]. Market Performance - According to data from the National Bureau of Statistics, the retail sales of cosmetics in December 2025 grew by 8.8% year-on-year, significantly outpacing the overall retail growth of 0.9%. The annual retail sales for cosmetics in 2025 reached 465.3 billion yuan, reflecting a 5.1% year-on-year increase [5]. Company Valuations - The report provides a valuation table for key companies, indicating their earnings per share (EPS) and price-to-earnings (PE) ratios for 2025E, 2026E, and 2027E. For instance, RuYuchen has an EPS of 0.59 yuan for 2025E with a PE of 60, while BeiTaiNi has an EPS of 1.10 yuan for 2025E with a PE of 43 [7].

Group 1 - A total of 7 companies had their restricted shares unlocked on February 6, with a combined unlock volume of 33.61 million shares, translating to a total unlock market value of 5.243 billion yuan based on the latest closing price [1] - The companies with the highest unlock volumes are Xinghuan Technology-U, Dengkang Dental, and Hansan Technology, with unlock share numbers of 27.16 million, 2.99 million, and 1.52 million shares respectively [1] - In terms of unlock market value, Xinghuan Technology-U, Dengkang Dental, and Hansan Technology also lead, with unlock market values of 4.985 billion yuan, 130 million yuan, and 8.616 million yuan respectively [1] Group 2 - The unlock share ratio relative to total share capital is highest for Xinghuan Technology-U, Dengkang Dental, and Hansan Technology, with ratios of 22.42%, 1.74%, and 1.18% respectively [1]

登录新浪财经APP 搜索【信披】查看更多考评等级 二、申请解除股份限售股东履行承诺情况 1.本次申请解除股份限售的股东重庆百货在《首次公开发行股票上市公告书》（以下简称"《上市公告 书》"）中作出的承诺情况如下： 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 特别提示： （一）本次解除限售的股份为重庆登康口腔护理用品股份有限公司（以下简称"登康口腔"或"公 司"或"发行人"）首次公开发行前限售股； （二）本次解除股份限售的股东户数为1名，即：重庆百货大楼股份有限公司（以下简称"重庆百 货"），解除限售股份数量为2,987,700股，占公司总股本的1.74%； （三）本次解除限售股份上市流通日期为2026年2月6日（星期五）。 一、首次公开发行前已发行股份概况 经中国证券监督管理委员会《关于同意重庆登康口腔护理用品股份有限公司首次公开发行股票注册的批 复》（证监许可〔2023〕585号）核准，并经深圳证券交易所《关于重庆登康口腔护理用品股份有限公 司人民币普通股股票上市的通知》（深证上〔2023〕278号）同意，公司首次公开发行人民币普通股股 票（A股）43, ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：001328 证券简称：登康口腔 公告编号：2026-006 重庆登康口腔护理用品股份有限公司 关于部分首次公开发行前限售股份上市流通的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 特别提示： （一）本次解除限售的股份为重庆登康口腔护理用品股份有限公司（以下简称"登康口腔"或"公 司"或"发行人"）首次公开发行前限售股； （二）本次解除股份限售的股东户数为1名，即：重庆百货大楼股份有限公司（以下简称"重庆百 货"），解除限售股份数量为2,987,700股，占公司总股本的1.74%； （三）本次解除限售股份上市流通日期为2026年2月6日（星期五）。 一、首次公开发行前已发行股份概况 二、申请解除股份限售股东履行承诺情况 1.本次申请解除股份限售的股东重庆百货在《首次公开发行股票上市公告书》（以下简称"《上市公告 书》"）中作出的承诺情况如下： ■ 经中国证券监督管理委员会《关于同意重庆登康口腔护理用品股份有限公司首次公开发行股票注册的批 复》（证监许可〔2023〕585号）核准，并经深圳 ...

证券代码：001328 证券简称：登康口腔 公告编号：2026-006 重庆登康口腔护理用品股份有限公司 关于部分首次公开发行前限售股份上市流通的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 特别提示： （一）本次解除限售的股份为重庆登康口腔护理用品股份有限公司（以下简称"登 康口腔"或"公司"或"发行人"）首次公开发行前限售股； （二）本次解除股份限售的股东户数为1名，即：重庆百货大楼股份有限公司（以 下简称"重庆百货"），解除限售股份数量为2,987,700股，占公司总股本的1.74%； （三）本次解除限售股份上市流通日期为2026年2月6日（星期五）。 一、首次公开发行前已发行股份概况 经中国证券监督管理委员会《关于同意重庆登康口腔护理用品股份有限公司首次 公开发行股票注册的批复》（证监许可〔2023〕585号）核准，并经深圳证券交易所 《关于重庆登康口腔护理用品股份有限公司人民币普通股股票上市的通知》（深证上 〔2023〕278号）同意，公司首次公开发行人民币普通股股票（A股）43,043,500股，并 于2023年4月10日在深圳证券交 ...